Heritage Cannabis Holdings (CANN.C) is now selling their Purefarma and Pura Vida products on their EndoDNA site myDNA.live as of today, according to a press release. Heritage’s Canadian launch…
EndoCanna
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers….
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”…
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate…
Heritage is positioning itself to radically expand its sales territory….
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….
Endocanna Health, a subsidiary of Heritage Cannabis (CANN.C), has agreed to manufacture and license its patent-pending Endocannabinoid DNA Test Kits to Empower Clinics (CBDT.C). Imagine a product tuned in…
Heritage Cannabis (CANN.C) is back in the headlines Wednesday after announcing plans to acquire a minority stake in EndoCanna, one of California’s leading DNA-testing marijuana companies. The news comes…